A Proposed Model for an Artificial Intelligence Algorithm to Improve Pharmaceutical Industry

An Artificial Intelligence (AI) is revolutionizing the pharmaceutical industry by enhancing and streamlining numerous processes, ranging from drug discovery to clinical trial optimization. AI technologies help accelerate processes, reduce costs, and improve effectiveness, enabling pharmaceutical companies to achieve long-term competitive advantages. This study aims to advance the pharmaceutical industry by designing a software solution that utilizes a genetic algorithm based on artificial intelligence. In this research, drug components are represented as genes within a set of chromosomes, allowing for the optimization of pharmaceutical molecule design by exploring vast spaces of possible chemical compounds. The proposed algorithm identifies the most effective molecules while minimizing potential side effects, significantly accelerating the drug discovery process by reducing the time and cost required to produce new or advanced formulations. This innovative approach holds the potential to transform drug development and improve outcomes in the pharmaceutical sector.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-02-27
DOI
https://doi.org/10.5281/zenodo.14930502
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Proposed Model for an Artificial Intelligence Algorithm to Improve Pharmaceutical Industry

Zenodo (CERN European Organization for Nuclear Research)
Computational Drug Discovery Methods
article

A Proposed Model for an Artificial Intelligence Algorithm to Improve Pharmaceutical Industry

article en

Abstract

An Artificial Intelligence (AI) is revolutionizing the pharmaceutical industry by enhancing and streamlining numerous processes, ranging from drug discovery to clinical trial optimization. AI technologies help accelerate processes, reduce costs, and improve effectiveness, enabling pharmaceutical companies to achieve long-term competitive advantages. This study aims to advance the pharmaceutical industry by designing a software solution that utilizes a genetic algorithm based on artificial intelligence. In this research, drug components are represented as genes within a set of chromosomes, allowing for the optimization of pharmaceutical molecule design by exploring vast spaces of possible chemical compounds. The proposed algorithm identifies the most effective molecules while minimizing potential side effects, significantly accelerating the drug discovery process by reducing the time and cost required to produce new or advanced formulations. This innovative approach holds the potential to transform drug development and improve outcomes in the pharmaceutical sector.

Zenodo (CERN European Organization for Nuclear Research)
Industry, innovation and infrastructure
Openalex Percentile: Top 58%
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.